{"gene":"CAMK2B","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1998,"finding":"CaMKIIβ (but not CaMKIIα) binds to F-actin in dendritic spines and cell cortex, functioning as a targeting module that localizes CaMKIIα/β heterooligomers to synaptic and cytoskeletal sites. When co-expressed, CaMKIIα and CaMKIIβ form large heterooligomers, and a small fraction of CaMKIIβ is sufficient to dock the predominant CaMKIIα to the actin cytoskeleton.","method":"GFP-tagged CaMKII isoform live imaging in neurons; co-expression heterooligomer analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct live-cell imaging with GFP fusions, replicated concept across multiple subsequent labs","pmids":["9768845"],"is_preprint":false},{"year":2006,"finding":"CaMKIIβ association with the F-actin cytoskeleton requires inclusion of alternatively spliced exon v1; the neonatal variant CaMKIIβe (lacking exon v1) fails to associate with F-actin. CaMKIIβ (but not CaMKIIα) bundles F-actin filaments in vitro and can phosphorylate actin in vitro even by basal (unstimulated) activity in the absence of Ca2+/CaM.","method":"Alternative splicing analysis with deletion constructs; F-actin bundling in vitro assay; in-cell F-actin co-localization; in vitro kinase assay on actin","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of F-actin bundling and phosphorylation plus cellular localization with multiple isoform constructs; findings replicated in subsequent papers","pmids":["16928958"],"is_preprint":false},{"year":2008,"finding":"CaMKIIβ binds preferentially to stable (vs. dynamic) F-actin in embryonic cortical neurons. CaMKIIβ binding to F-actin is disrupted by Ca2+/calmodulin binding or by high phosphorylation, but not by kinase inactivity. CaMKIIβ over-expression increased F-actin-rich structures, while disruption of its F-actin binding reduced them, indicating CaMKIIβ binding to stable F-actin maintains polymerized F-actin in vivo.","method":"FRAP of GFP-CaMKIIβ in CaMKIIα-free embryonic cortical neurons; pharmacological F-actin stabilization/destabilization; deletion mutant analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — FRAP with functional rescue and multiple mutant constructs in a clean CaMKIIα-free system","pmids":["18840684"],"is_preprint":false},{"year":2011,"finding":"CaMKIIβ operates at the centrosome (localized there by the targeting protein PCM1) in a CaMKIIα-independent manner to drive dendrite retraction and pruning. CaMKIIβ phosphorylates the E3 ubiquitin ligase substrate Cdc20 at Ser51, inducing Cdc20 dispersion from the centrosome, inhibiting centrosomal Cdc20-APC activity, and triggering the transition from dendrite growth to retraction.","method":"Knockdown in primary rat neurons and in vivo in rat cerebellar cortex; identification of PCM1 as centrosomal targeting partner; in vitro kinase assay identifying Cdc20 Ser51 as CaMKIIβ phosphorylation site; Cdc20-APC activity assay","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay with defined phosphosite, in vivo knockdown, and identification of upstream targeting partner PCM1; multiple orthogonal methods","pmids":["21725312"],"is_preprint":false},{"year":2012,"finding":"Arc/Arg3.1 interacts with high affinity with CaMKIIβ that is not bound to calmodulin. Arc accumulates at inactive synapses via this interaction, leading to AMPA-R (GluA1) endocytosis. Loss of CaMKIIβ in vitro or in vivo abolished Arc upregulation at silenced synapses, establishing CaMKIIβ as the targeting receptor for Arc in 'inverse synaptic tagging'.","method":"Co-immunoprecipitation; in vivo CaMKIIβ knockout; immunofluorescence for surface GluA1; synaptic activity manipulations","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding experiments with genetic KO validation in vitro and in vivo, multiple orthogonal readouts","pmids":["22579289"],"is_preprint":false},{"year":2013,"finding":"CaMKIIβ is critical for the morphological maturation of differentiating oligodendrocytes and regulates myelin thickness in vivo. CaMKIIβ has an actin-cytoskeleton-stabilizing role in oligodendrocytes, and its in vivo function in myelin thickness may be mediated by non-kinase-catalytic (structural) activity, as shown using Camk2b knockout and Camk2b(A303R) kinase-dead mutant mice.","method":"In vitro oligodendrocyte culture with CaMKIIβ manipulation; Camk2b knockout mice; Camk2b(A303R) kinase-dead knock-in mice; myelin thickness measurement","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (KO and kinase-dead knock-in) with in vitro and in vivo phenotypic readouts","pmids":["23785157"],"is_preprint":false},{"year":2013,"finding":"CaMKIIβ (but not CaMKIIα) is required for BDNF-induced neuritogenesis. CaMKIIβ phosphorylates LIM-kinase 1 (LIMK1) at Thr-508 in the kinase domain, activating LIMK1's cofilin-phosphorylating activity, which in turn drives actin cytoskeletal reorganization and primary neurite formation.","method":"CaMKIIβ knockdown in cortical neurons; in vitro kinase assay identifying LIMK1 Thr-508 phosphorylation; kinase-dead LIMK1 mutant rescue; pharmacological CaMK inhibition","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with defined phosphosite plus cellular knockdown and rescue, single lab but two orthogonal methods","pmids":["23600483"],"is_preprint":false},{"year":2015,"finding":"CaMKIIβ promotes spine formation and elongation in cerebellar Purkinje cells through its F-actin bundling activity. Activation of group I mGluR (but not AMPAR) triggers PKC-mediated phosphorylation of CaMKIIβ, causing dissociation of the CaMKIIβ/F-actin complex. Defective PKC-mediated CaMKIIβ phosphorylation promotes excess F-actin bundling and leads to abnormally numerous and elongated spines.","method":"Purkinje cell spine morphology analysis; pharmacological mGluR activation; PKC inhibition; CaMKIIβ phosphorylation assay; IP3R1-deficient mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mouse model combined with pharmacological dissection of mGluR/PKC pathway and direct measurement of CaMKIIβ/F-actin complex","pmids":["28607044"],"is_preprint":false},{"year":2016,"finding":"Normal locomotion requires Ca2+/calmodulin-mediated activation of CAMK2B, but CAMK2B autonomous (Ca2+-independent) activity is largely dispensable. Severe locomotion deficits in Camk2b−/− mice are largely of developmental origin, as adult-onset deletion causes only mild deficits. These deficits cannot be attributed to a single brain area (cerebellum, striatum, or forebrain).","method":"Conditional Camk2b knockout (Camk2b(f/f)); Camk2b(T287A) knock-in (autonomous activity block); temporal and region-specific Cre-mediated deletion; behavioral locomotion assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models with temporal and regional specificity; multiple orthogonal behavioral readouts","pmids":["27244486"],"is_preprint":false},{"year":2017,"finding":"De novo mutations in CAMK2B that alter auto-phosphorylation at Thr287 (either decreasing or increasing it) also impair neuronal migration in vitro and in vivo, establishing that tightly regulated CAMK2B auto-phosphorylation is required for normal neuronal migration and brain development.","method":"Whole-exome sequencing; CAMK2 auto-phosphorylation assays in cell lines; neuronal migration assays in vitro and in vivo","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent human mutations tested with direct phosphorylation assays and neuronal migration functional assay","pmids":["29100089"],"is_preprint":false},{"year":2018,"finding":"CaMKIIβ controls radial migration of cortical projection neurons through its actin-binding and -bundling activities; knockdown accelerates migration while overexpression inhibits it. A fine-tuned balance between CaMKIIβ and cofilin activities is necessary for proper neuronal migration, placing CaMKIIβ upstream of actin dynamics in cortical neuron locomotion.","method":"In utero electroporation with CaMKIIβ knockdown/overexpression and actin-binding domain mutants; analysis of multipolar-bipolar transition and locomotion in cortical plate","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo in utero electroporation with domain-specific mutants and multiple cellular phenotype readouts","pmids":["29712998"],"is_preprint":false},{"year":2018,"finding":"Autophosphorylation at the F-actin binding domain of CaMKIIβ is required for fear learning. Phosphoblock mutations in the actin-binding domain (knock-in mice) impair contextual and cued fear conditioning, demonstrating that proper regulation of CaMKIIβ–F-actin interaction is important for learning and memory.","method":"CaMKIIβ F-actin binding domain phosphoblock knock-in mice; contextual and cued fear conditioning behavioral tests","journal":"Neurobiology of learning and memory","confidence":"High","confidence_rationale":"Tier 2 / Strong — knock-in mouse model with defined phosphosite mutation and direct behavioral phenotype","pmids":["30528771"],"is_preprint":false},{"year":2018,"finding":"CaMKIIβ is localized in dendritic spines as both drebrin-dependent and drebrin-independent pools. Drebrin knockdown causes diffuse localization of CaMKIIβ and increases the stable CaMKIIβ fraction. NMDA receptor activation releases CaMKIIβ from the drebrin-binding F-actin complex, shifting CaMKIIβ association to the PSD.","method":"Yeast two-hybrid identification of drebrin–CaMKIIβ interaction; FRAP analysis in rat hippocampal neurons; drebrin knockdown; NMDA receptor activation","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus FRAP in neurons plus genetic knockdown, multiple orthogonal methods","pmids":["29675826"],"is_preprint":false},{"year":2019,"finding":"Both Ca2+-dependent and Ca2+-independent (autonomous) activity of CAMK2 are essential for survival. Combined loss of CAMK2A and CAMK2B abolishes LTP but does not affect synaptic transmission or the biochemical composition of the postsynaptic density, demonstrating that CAMK2 signaling is required for postnatal development and mature brain function beyond PSD structural organization.","method":"Germline and adult-inducible Camk2a/Camk2b double knockout mice; Ca2+-dependent/autonomous activity mutant mice; LTP electrophysiology; PSD biochemical fractionation; brain morphology","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models with activity-specific mutations; multiple orthogonal phenotypic and biochemical readouts","pmids":["31064859"],"is_preprint":false},{"year":2019,"finding":"CaMKIIβ interacts with GSK3β and opposes its activity in oligodendrocytes. HIV-1 Tat increases CaMKIIβ activity in oligodendrocytes; pharmacological or genetic inhibition of CaMKIIβ increases GSK3β activity and promotes death in mature oligodendrocytes treated with Tat, showing that CaMKIIβ–GSK3β interaction determines oligodendrocyte viability.","method":"CaMKII inhibitor (KN-93) treatment; CaMKIIβ knockdown in oligodendrocyte cultures; GSK3β activity assay; cell viability assays; in vivo Tat transgenic mice","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown and pharmacological inhibition in vitro plus in vivo model, single lab","pmids":["30674062"],"is_preprint":false},{"year":2021,"finding":"CAMK2 activation disrupts adipocyte insulin signaling and lowers insulin receptor levels, contributes to lipolysis and TNFα-induced inflammation. Adipocyte-specific CAMK2 deletion in obese mice improved glucose intolerance and insulin resistance, establishing CAMK2 as a regulator of adipocyte metabolic function.","method":"Conditional adipocyte-specific CAMK2 knockout mice; in vitro differentiated adipocytes; insulin signaling analysis; glucose and insulin tolerance tests","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional genetic knockout with in vivo metabolic phenotyping and in vitro mechanistic follow-up; multiple orthogonal readouts","pmids":["34303021"],"is_preprint":false},{"year":2021,"finding":"CAMK2/CaMKII (including the β isoform) phosphorylates MLKL in a RIPK3-independent manner during short-term nutrient starvation, facilitating autophagic flux by promoting autophagosome maturation and fusion with lysosomes, independent of necroptosis.","method":"Genetic knockdown/knockout of CAMK2 and MLKL in multiple cell lines; pharmacological inhibition; LC3-II and p62 flux assays; pHluorin-mKate2-LC3 autolysosome incorporation assay","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic and pharmacological approaches across multiple cell lines with direct autophagic flux readouts","pmids":["34282994"],"is_preprint":false},{"year":2021,"finding":"CaMKIIβ-mediated phosphorylation of TARPγ-8 enhances GluA1 AMPA receptor expression at postsynaptic sites in the ventral hippocampus, enabling stress resilience; this CaMKIIβ/TARPγ-8/AMPAR pathway mediates gene-environment interactions controlling behavioral susceptibility and resilience to chronic stress.","method":"CaMKIIβ activity manipulation in vivo in ventral hippocampus; phosphorylation assays; GluA1 surface expression measurement; behavioral stress paradigms in GxE mouse models","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo manipulation with phosphorylation and receptor expression readouts, single lab","pmids":["34113835"],"is_preprint":false},{"year":2022,"finding":"Distinct phosphorylation states of CaMKIIβ differentially control sleep induction versus sleep maintenance: a mutant mimicking constitutive-active auto-phosphorylation promotes wakefulness-to-sleep transition, while mutants mimicking subsequent multisite auto-phosphorylation suppress sleep-to-wakefulness transition. Sleep regulation depends on CaMKIIβ kinase activity.","method":"Camk2b knockout mice; CaMKIIβ activation/inhibition in mice; phosphomimetic and phosphoblock CaMKIIβ mutants; EEG sleep duration/state analysis","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple phosphorylation-state mutants with in vivo EEG sleep phenotyping","pmids":["36194579"],"is_preprint":false},{"year":2022,"finding":"Primate-specific CAMK2B alternative splice isoforms (generated through evolutionarily weakened branch point sequences) show altered kinetic properties and changed substrate specificity. Introducing a weaker human branch point sequence into mouse Camk2b via CRISPR/Cas9 strongly alters splicing in brain and severely impairs LTP at CA3-CA1 synapses.","method":"Identification of primate-specific CAMK2B isoforms; in vitro kinase assays of splice isoforms; CRISPR/Cas9 knock-in of human branch point into mouse; LTP electrophysiology in hippocampal slices","journal":"Life science alliance","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assays plus CRISPR knock-in mouse model with electrophysiological functional validation","pmids":["36543542"],"is_preprint":false},{"year":2022,"finding":"CaMKIIβ knockdown reduces store-operated calcium entry (nSOCE) amplitude in dendritic spines of hippocampal neurons and causes mushroom spine loss, linking CaMKIIβ to regulation of spine calcium homeostasis and structural maintenance.","method":"CaMKIIβ knockdown by siRNA in primary hippocampal neurons; calcium imaging for nSOCE; spine morphology analysis; pharmacological CaMKII inhibition (KN-62)","journal":"IBRO neuroscience reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown plus pharmacological inhibition with calcium imaging readout, single lab","pmids":["35079728"],"is_preprint":false},{"year":2022,"finding":"Super-resolution STORM imaging shows CaMKIIβ co-localizes with drebrin in the core region of dendritic spines; NMDA receptor activation dissociates CaMKIIβ from drebrin in the core region. Drebrin knockdown decreases CaMKIIβ in the core but not the submembrane region, establishing drebrin-dependent clustering of CaMKIIβ in the spine core as a resting-state standby arrangement.","method":"STORM super-resolution microscopy; NMDA receptor activation; drebrin knockdown in hippocampal neurons","journal":"Neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — super-resolution imaging with genetic knockdown, single lab","pmids":["37659612"],"is_preprint":false},{"year":2023,"finding":"CaMKIIβ activates ERK1/2, which then phosphorylates GABAB1 at S867 and T872, triggering lysosomal degradation of GABAB receptors. Mutational inactivation of T872 or blocking ERK1/2 prevents receptor degradation, revealing that CaMKIIβ does not directly phosphorylate S867 but instead acts upstream of ERK1/2 in the GABAB receptor degradation pathway.","method":"Site-directed mutagenesis of GABAB1 phosphosites; ERK1/2 inhibition; CaMKIIβ manipulation; receptor degradation assays in cultured neurons under physiological and ischemic conditions","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — site-directed mutagenesis of defined phosphosites combined with epistasis (CaMKIIβ → ERK1/2 → GABAB1) in neurons","pmids":["37686242"],"is_preprint":false},{"year":2024,"finding":"CaMKIIβ hub domains adopt both 14-mer and 16-mer oligomeric assemblies that coexist in solution. CaMKIIβ hub is less stable than CaMKIIα hub, with larger oligomers being more stable. A dimeric CaMKIIβ hub unit created by rational mutagenesis is significantly less stable than the oligomer, and both hubs populate an intermediate during unfolding.","method":"X-ray crystallography (3.1 Å 14-mer and 3.4 Å 16-mer crystal structures); mass photometry; temperature denaturation; rational mutagenesis to create dimer","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — two crystal structures plus mass photometry and biophysical stability analyses in single study","pmids":["38501502"],"is_preprint":false},{"year":2024,"finding":"CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I. CaMKIIβ/βM overexpression normalizes endplate fragmentation and corrects aberrant synaptic gene expression (including abnormal HDAC4 accumulation) in innervated Mbnl1ΔE3/ΔE3 muscle, placing CaMKIIβ upstream of HDAC4-regulated synaptic gene programs.","method":"HSALR and Mbnl1ΔE3/ΔE3 DM1 mouse models; AAV-mediated CaMKIIβ overexpression; endplate morphology; synaptic gene expression; HDAC4 immunostaining; AChR turnover assays","journal":"Skeletal muscle","confidence":"High","confidence_rationale":"Tier 2 / Strong — two genetic DM1 mouse models with rescue by CaMKIIβ overexpression and multiple molecular and morphological readouts","pmids":["38769542"],"is_preprint":false},{"year":2025,"finding":"CaMKIIβ interacts with and phosphorylates spastin at Ser233 and Ser562, reducing its polyubiquitination and suppressing proteasomal degradation, thereby increasing spastin protein stability, enhancing its microtubule-severing activity, and promoting neurite outgrowth in hippocampal neurons.","method":"Co-IP identifying CaMKIIβ–spastin interaction; in vitro kinase assay mapping Ser233/Ser562 phosphosites; ubiquitination assays; proteasomal degradation assays; neurite outgrowth analysis; mEPSC electrophysiology; behavioral tests (Y-maze, Morris water maze)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay with defined phosphosites, ubiquitination mechanistic follow-up, and in vivo behavioral validation; multiple orthogonal methods","pmids":["40645772"],"is_preprint":false},{"year":2018,"finding":"Calpain 3 (CAPN3) colocalizes with CaMKIIβ at the muscle triad; CAPN3 knockout reduces triad integrity and blunts CaMKIIβ signaling, impairing transcriptional activation of myofibrillar and oxidative metabolism genes in response to exercise and during muscle reloading after atrophy. CaMKIIβ signaling is required for induction of HSP70 and the inflammatory response needed for muscle recovery.","method":"CAPN3 knockout mice; hindlimb unloading/reloading model; CaMKIIβ activation measurement; RNA-sequencing; HSP70 expression; immune cell infiltration analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with RNA-seq and multiple molecular readouts, single lab","pmids":["29528394"],"is_preprint":false},{"year":2020,"finding":"CaMKIIβ specifically (among the four CaMKII isoforms) enhances the surface expression and channel activity of the Ca2+-activated chloride channel ANO1 in glioblastoma cells. Gene silencing of CaMKIIβ suppresses ANO1 surface expression and channel activity and reduces migration and invasion of glioblastoma cells.","method":"KN-93 pharmacological inhibition; CaMKIIβ siRNA knockdown; heterologous expression of individual CaMKII isoforms; ANO1 surface expression assay; patch-clamp electrophysiology; migration/invasion assays","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific knockdown and heterologous expression with electrophysiological and cell biological readouts, single lab","pmids":["32357567"],"is_preprint":false},{"year":2022,"finding":"ERK1/2 is identified as an important linker downstream of CaMKIIβ affecting synaptic protein expression in hippocampal neurons; CaMKIIβ overexpression or underexpression leads to different profiles of synaptic protein changes, with Mapk3 (ERK1) as a candidate target linking CaMKIIβ dysregulation to synaptogenesis.","method":"Lentiviral CaMKIIβ overexpression and knockdown in rat hippocampal neurons; iTRAQ-based quantitative proteomics; immunoblot validation; protein interaction network analysis","journal":"Neuroscience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — proteomics-based association with immunoblot confirmation, no direct phosphorylation or interaction experiment for CaMKIIβ→ERK, single lab","pmids":["36041587"],"is_preprint":false},{"year":2014,"finding":"Alternative splicing of the CaMKIIβ variable region determines F-actin association in developing neurons: exon E1 is required for F-actin association, while exon E4 assists but is not required. CaMKIIβ isoforms lacking E1 (βe and β'e) do not associate with F-actin microspikes in embryonic cortical neurons.","method":"Expression of CaMKIIβ splice variants with and without E1/E4 in E18 rat cortical neurons; co-localization with F-actin microspike structures","journal":"International journal of clinical and experimental pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell biological analysis of multiple defined splice variants in a clean CaMKIIα-free system, consistent with prior in vitro work","pmids":["25031715"],"is_preprint":false},{"year":2026,"finding":"Phosphoproteomic analysis of CaMKIIα/CaMKIIβ double-knockout cortical tissue identified 130 proteins with reduced phosphorylation, including 113 not previously known as CaMKII substrates, and provided new in vivo data on the CaMKII substrate consensus sequence.","method":"Inducible Camk2a/Camk2b double KO mice; mass spectrometry-based phosphoproteomics; comparison of 5622 phosphopeptides from 2080 proteins","journal":"ACS chemical neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — unbiased in vivo phosphoproteomic screen in double KO vs WT; rigorous genetic model but no direct phosphorylation validation for individual substrates in this study","pmids":["41740964"],"is_preprint":false},{"year":2024,"finding":"CaMKIIβ hub domain crystal structures reveal coexisting 14-mer and 16-mer assemblies. The CaMKIIβ hub is significantly less thermodynamically stable than the CaMKIIα hub, and larger oligomers are more stable than smaller ones.","method":"X-ray crystallography at 3.1 Å (14-mer) and 3.4 Å (16-mer); mass photometry; temperature denaturation experiments; rational mutagenesis to produce dimer","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — two crystal structures from the same crystallization drop plus orthogonal biophysical analyses; single lab but rigorous multi-method approach","pmids":["38501502"],"is_preprint":false}],"current_model":"CaMKIIβ is a Ca2+/calmodulin-activated serine/threonine kinase that is uniquely distinguished from CaMKIIα by an alternatively spliced variable domain (requiring exon v1) that enables direct binding and bundling of F-actin, targeting heterooligomeric CaMKIIα/β complexes to dendritic spines; activation by Ca2+/calmodulin or autophosphorylation releases CaMKIIβ from the actin cytoskeleton, creating a regulated structural-to-signaling switch that controls spine morphology, actin stability, LTP, fear learning, neuronal migration, dendrite patterning (via centrosomal phosphorylation of Cdc20-APC), Arc-mediated inverse synaptic tagging, LIMK1 activation, GABAB receptor degradation (via ERK1/2), spastin stabilization, oligodendrocyte maturation, sleep regulation, and autophagy, while its hub domain assembles into coexisting 14-mer and 16-mer oligomers that are distinctly less stable than those of CaMKIIα."},"narrative":{"mechanistic_narrative":"CaMKIIβ is a Ca2+/calmodulin-activated serine/threonine kinase that doubles as a structural actin-organizing protein, coupling calcium signaling to cytoskeletal dynamics in neurons [PMID:9768845, PMID:16928958]. Its distinguishing feature is an alternatively spliced variable domain (requiring exon v1/E1) that confers direct F-actin binding and bundling not shared by CaMKIIα; CaMKIIβ thereby targets CaMKIIα/β heterooligomers to dendritic spines and the cell cortex, and isoforms lacking this exon fail to associate with F-actin [PMID:9768845, PMID:16928958, PMID:25031715]. CaMKIIβ binds preferentially to stable F-actin and maintains polymerized actin in vivo, an association released by Ca2+/calmodulin binding, autophosphorylation, or PKC-mediated phosphorylation, creating a regulated structural-to-signaling switch that governs spine formation, elongation, and maintenance [PMID:18840684, PMID:28607044, PMID:30528771, PMID:35079728]. Through this actin-binding/bundling activity CaMKIIβ controls radial migration of cortical neurons in balance with cofilin, and tightly regulated Thr287 autophosphorylation—both gains and losses—impairs neuronal migration and underlies a neurodevelopmental disorder caused by de novo CAMK2B mutations [PMID:29100089, PMID:29712998]. As a kinase, CaMKIIβ phosphorylates defined substrates to remodel the cytoskeleton and synapse: LIMK1 at Thr508 to drive BDNF-induced neuritogenesis [PMID:23600483], Cdc20 at Ser51 at the PCM1-targeted centrosome to inhibit Cdc20-APC and trigger dendrite retraction [PMID:21725312], and spastin at Ser233/Ser562 to stabilize it against proteasomal degradation and promote neurite outgrowth [PMID:40645772]. It also acts non-catalytically and through partner recruitment—serving as the calmodulin-free receptor for Arc in inverse synaptic tagging [PMID:22579289], scaffolding with drebrin in the spine core as a resting-state arrangement released by NMDA receptor activation [PMID:29675826, PMID:37659612], and acting upstream of ERK1/2 to drive GABAB receptor lysosomal degradation [PMID:37686242]. CaMKIIβ activity is required for LTP, fear learning, locomotion, and sleep regulation [PMID:30528771, PMID:31064859, PMID:36194579, PMID:36543542], and beyond the nervous system it regulates autophagic flux via MLKL phosphorylation [PMID:34282994], adipocyte insulin signaling [PMID:34303021], and oligodendrocyte maturation and viability through actin stabilization and GSK3β antagonism [PMID:23785157, PMID:30674062]. Structurally, the CaMKIIβ hub domain assembles into coexisting 14-mer and 16-mer oligomers that are less stable than those of CaMKIIα [PMID:38501502].","teleology":[{"year":1998,"claim":"Established that CaMKIIβ, unlike CaMKIIα, binds F-actin and acts as a targeting module that docks CaMKII heterooligomers to dendritic spines, defining a non-catalytic localization function distinct from kinase activity.","evidence":"GFP-tagged CaMKII isoform live imaging and co-expression heterooligomer analysis in neurons","pmids":["9768845"],"confidence":"High","gaps":["Did not define the structural determinant within CaMKIIβ responsible for F-actin binding","Did not establish how the interaction is regulated"]},{"year":2006,"claim":"Identified the alternatively spliced exon v1 as the determinant of F-actin association and showed CaMKIIβ bundles and phosphorylates actin, linking the splice-defined domain to both structural and enzymatic actions on the cytoskeleton.","evidence":"Splice deletion constructs, in vitro F-actin bundling, in-cell co-localization, and in vitro kinase assay on actin","pmids":["16928958"],"confidence":"High","gaps":["Functional consequence of actin phosphorylation in vivo not resolved","Did not address regulation by Ca2+/CaM in cells"]},{"year":2008,"claim":"Showed CaMKIIβ selectively binds stable F-actin and maintains polymerized actin, and that Ca2+/calmodulin or high phosphorylation (not kinase inactivity) releases it, defining the regulated structural-to-signaling switch.","evidence":"FRAP of GFP-CaMKIIβ in CaMKIIα-free cortical neurons with pharmacological actin manipulation and deletion mutants","pmids":["18840684"],"confidence":"High","gaps":["Specific phosphosites controlling release not mapped here","Downstream effects of actin stabilization on synaptic function not addressed"]},{"year":2011,"claim":"Defined a CaMKIIα-independent centrosomal function: CaMKIIβ phosphorylates Cdc20 at Ser51 to inhibit Cdc20-APC and drive dendrite retraction, extending CaMKIIβ substrate biology beyond actin.","evidence":"Neuronal knockdown in vitro and in vivo, PCM1 targeting identification, in vitro kinase assay mapping Cdc20 Ser51, and Cdc20-APC activity assay","pmids":["21725312"],"confidence":"High","gaps":["How CaMKIIβ activity at the centrosome is triggered remains unclear","Relationship between centrosomal and spine pools not defined"]},{"year":2012,"claim":"Established CaMKIIβ as the calmodulin-free targeting receptor for Arc, mechanistically linking synaptic inactivity to AMPA receptor endocytosis in inverse synaptic tagging.","evidence":"Co-immunoprecipitation, CaMKIIβ knockout in vitro and in vivo, surface GluA1 immunofluorescence, and synaptic activity manipulation","pmids":["22579289"],"confidence":"High","gaps":["Structural basis of the calmodulin-state-dependent Arc binding not resolved","Whether kinase activity is involved not addressed"]},{"year":2013,"claim":"Identified LIMK1 Thr508 as a CaMKIIβ substrate driving BDNF-induced neuritogenesis and showed CaMKIIβ (not α) is required, connecting CaMKIIβ to the cofilin/actin reorganization pathway.","evidence":"CaMKIIβ knockdown in cortical neurons, in vitro kinase assay, and kinase-dead LIMK1 rescue","pmids":["23600483"],"confidence":"High","gaps":["In vivo requirement for LIMK1 phosphorylation by CaMKIIβ not tested","Single-lab finding"]},{"year":2013,"claim":"Demonstrated CaMKIIβ is required for oligodendrocyte maturation and myelin thickness, and that this function may be largely non-catalytic, broadening its role beyond neurons and beyond kinase activity.","evidence":"Oligodendrocyte cultures, Camk2b knockout mice, and Camk2b(A303R) kinase-dead knock-in mice with myelin thickness measurement","pmids":["23785157"],"confidence":"High","gaps":["The structural mechanism mediating myelin thickness not defined","Partner proteins in oligodendrocytes not identified here"]},{"year":2016,"claim":"Distinguished developmental from acute requirements: Ca2+/calmodulin activation (not autonomous activity) is needed for locomotion, and deficits arise developmentally and are not localized to one brain region.","evidence":"Conditional Camk2b knockout, Camk2b(T287A) autonomy-block knock-in, and temporal/regional Cre deletion with behavioral assays","pmids":["27244486"],"confidence":"High","gaps":["Specific developmental circuit affected not pinpointed","Molecular substrates underlying locomotion not identified"]},{"year":2017,"claim":"Established that tightly regulated Thr287 autophosphorylation is essential for neuronal migration and brain development, linking de novo CAMK2B mutations to a neurodevelopmental disorder.","evidence":"Whole-exome sequencing, autophosphorylation assays, and neuronal migration assays in vitro and in vivo","pmids":["29100089"],"confidence":"High","gaps":["Downstream migration substrates of CaMKIIβ not defined here","Genotype-phenotype correlations across patients not fully resolved"]},{"year":2018,"claim":"Showed CaMKIIβ controls cortical radial migration through actin binding/bundling in balance with cofilin, and that F-actin-binding-domain autophosphorylation is required for fear learning, tying its structural switch directly to behavior.","evidence":"In utero electroporation with domain mutants; F-actin binding domain phosphoblock knock-in mice with fear conditioning","pmids":["29712998","30528771"],"confidence":"High","gaps":["How migration and learning phenotypes mechanistically connect not defined","Precise kinetics of the actin-binding switch in vivo unresolved"]},{"year":2018,"claim":"Identified drebrin as a CaMKIIβ partner organizing a resting-state pool in the spine core that is released by NMDA receptor activation, defining how CaMKIIβ is positioned for activity-dependent redistribution.","evidence":"Yeast two-hybrid, FRAP in hippocampal neurons, drebrin knockdown, and NMDA receptor activation (later refined by STORM imaging)","pmids":["29675826","37659612"],"confidence":"High","gaps":["Functional output of drebrin-dependent versus -independent pools not fully separated","Whether drebrin binding requires kinase activity not addressed"]},{"year":2019,"claim":"Demonstrated both Ca2+-dependent and autonomous CaMKII activity are essential for survival and LTP without altering PSD composition, separating CaMKII signaling from structural scaffolding of the postsynaptic density.","evidence":"Germline and adult-inducible Camk2a/Camk2b double knockouts, activity mutant mice, LTP electrophysiology, and PSD fractionation","pmids":["31064859"],"confidence":"High","gaps":["Isoform-specific contributions of CaMKIIβ within the double KO not isolated","Substrates mediating survival not identified here"]},{"year":2019,"claim":"Showed CaMKIIβ antagonizes GSK3β to determine oligodendrocyte viability in an HIV-1 Tat model, adding a viability-control axis to CaMKIIβ oligodendrocyte biology.","evidence":"KN-93 inhibition and CaMKIIβ knockdown in oligodendrocyte cultures, GSK3β activity and viability assays, and Tat transgenic mice","pmids":["30674062"],"confidence":"Medium","gaps":["Whether CaMKIIβ directly phosphorylates GSK3β not established","Single-lab finding"]},{"year":2021,"claim":"Extended CaMKIIβ (and CaMKII broadly) into non-neuronal physiology: regulating autophagic flux via MLKL phosphorylation, adipocyte insulin signaling, and stress resilience via TARPγ-8/AMPAR.","evidence":"Genetic/pharmacological MLKL studies with autophagy flux assays; adipocyte-specific CAMK2 knockout with metabolic phenotyping; in vivo ventral hippocampus manipulation with phosphorylation and behavioral readouts","pmids":["34282994","34303021","34113835"],"confidence":"High","gaps":["Isoform-specific contribution of CaMKIIβ in autophagy and adipocyte roles not fully separated from other CaMKII isoforms","MLKL and TARPγ-8 phosphosite mapping for CaMKIIβ not detailed here"]},{"year":2022,"claim":"Showed distinct CaMKIIβ autophosphorylation states differentially control sleep induction versus maintenance, and that primate-specific splice isoforms with altered kinetics affect LTP, linking phospho-state and splicing to higher functions.","evidence":"Phosphomimetic/phosphoblock mutants with EEG sleep analysis; CRISPR knock-in of human branch point into mouse with LTP electrophysiology","pmids":["36194579","36543542"],"confidence":"High","gaps":["Circuit-level basis of sleep-state control not resolved","Substrate-specificity changes of primate isoforms not fully mapped"]},{"year":2022,"claim":"Linked CaMKIIβ to spine calcium homeostasis, showing knockdown reduces store-operated calcium entry and causes mushroom spine loss.","evidence":"siRNA knockdown in hippocampal neurons with calcium imaging, spine morphology, and KN-62 inhibition","pmids":["35079728"],"confidence":"Medium","gaps":["Mechanism connecting CaMKIIβ to nSOCE channels not defined","Single-lab finding"]},{"year":2023,"claim":"Defined an indirect signaling route: CaMKIIβ activates ERK1/2, which phosphorylates GABAB1 to trigger lysosomal receptor degradation, showing CaMKIIβ acts upstream rather than directly on the receptor.","evidence":"Site-directed mutagenesis of GABAB1 phosphosites, ERK1/2 inhibition, and CaMKIIβ manipulation with degradation assays under physiological and ischemic conditions","pmids":["37686242"],"confidence":"High","gaps":["The direct CaMKIIβ substrate linking it to ERK1/2 activation not identified","Physiological context of GABAB downregulation incompletely defined"]},{"year":2024,"claim":"Resolved the CaMKIIβ hub architecture, showing coexisting 14-mer and 16-mer assemblies that are less stable than CaMKIIα hubs, providing a structural basis for isoform-specific oligomer behavior.","evidence":"X-ray crystallography (3.1 Å 14-mer, 3.4 Å 16-mer), mass photometry, temperature denaturation, and rational dimer mutagenesis","pmids":["38501502"],"confidence":"High","gaps":["Functional consequence of variable oligomer size in cells not established","Relationship of hub stability to actin targeting not addressed"]},{"year":2024,"claim":"Implicated CaMKIIβ in neuromuscular junction stability, showing CaMKIIβ overexpression normalizes endplate fragmentation and corrects HDAC4-regulated synaptic gene programs in Myotonic Dystrophy type I models.","evidence":"HSALR and Mbnl1ΔE3/ΔE3 DM1 mouse models with AAV CaMKIIβ overexpression, endplate morphology, gene expression, and AChR turnover assays","pmids":["38769542"],"confidence":"High","gaps":["Direct CaMKIIβ substrates at the NMJ not identified","Whether kinase activity mediates the rescue not separated"]},{"year":2025,"claim":"Identified spastin as a CaMKIIβ substrate (Ser233/Ser562) stabilized against degradation, mechanistically connecting CaMKIIβ to microtubule severing and neurite outgrowth.","evidence":"Co-IP, in vitro kinase assay mapping phosphosites, ubiquitination and degradation assays, neurite outgrowth, mEPSC recording, and behavioral tests","pmids":["40645772"],"confidence":"High","gaps":["In vivo requirement for spastin phosphorylation by CaMKIIβ across tissues not established","How phosphorylation reduces ubiquitination mechanistically not detailed"]},{"year":null,"claim":"How the distinct molecular axes of CaMKIIβ — actin structural targeting, defined substrate phosphorylation (Cdc20, LIMK1, spastin, MLKL), and scaffold/receptor functions (Arc, drebrin) — are coordinated through its splice variants, phospho-state, and hub oligomerization within a single cell remains unresolved, and the bulk of its in vivo substrate landscape is still being defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Most CaMKII substrates identified by phosphoproteomics in double-KO tissue lack direct validation [#30]","No unified model relating hub stability/oligomer size to functional output","Isoform-specific versus shared functions across CaMKIIα/β incompletely separated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[3,6,16,22,25]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,1,2,7,10,29]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,3,6,25]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,8,13]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[5,23]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,1,2,29]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[3]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,27]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,13,17,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,9,10,5]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[14,15,22]}],"complexes":["CaMKII holoenzyme (CaMKIIα/β heterooligomer)"],"partners":["CAMK2A","ARC","PCM1","CDC20","DBN1","LIMK1","SPAST","GSK3B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13554","full_name":"Calcium/calmodulin-dependent protein kinase type II subunit beta","aliases":[],"length_aa":666,"mass_kda":72.7,"function":"Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in dendritic spine and synapse formation, neuronal plasticity and regulation of sarcoplasmic reticulum Ca(2+) transport in skeletal muscle (PubMed:16690701). In neurons, plays an essential structural role in the reorganization of the actin cytoskeleton during plasticity by binding and bundling actin filaments in a kinase-independent manner. This structural function is required for correct targeting of CaMK2A, which acts downstream of NMDAR to promote dendritic spine and synapse formation and maintain synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. In developing hippocampal neurons, promotes arborization of the dendritic tree and in mature neurons, promotes dendritic remodeling. Also regulates the migration of developing neurons (PubMed:29100089). Participates in the modulation of skeletal muscle function in response to exercise (PubMed:16690701). In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through phosphorylation of triadin, a ryanodine receptor-coupling factor, and phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2. In response to interferon-gamma (IFN-gamma) stimulation, catalyzes phosphorylation of STAT1, stimulating the JAK-STAT signaling pathway (By similarity). Phosphorylates reticulophagy regulator RETREG1 at 'Ser-151' under endoplasmic reticulum stress conditions which enhances RETREG1 oligomerization and its membrane scission and reticulophagy activity (PubMed:31930741)","subcellular_location":"Cytoplasm, cytoskeleton; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Sarcoplasmic reticulum membrane; Synapse","url":"https://www.uniprot.org/uniprotkb/Q13554/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CAMK2B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM1","stoichiometry":0.2},{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CAMK2B","total_profiled":1310},"omim":[{"mim_id":"617799","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 54; MRD54","url":"https://www.omim.org/entry/617799"},{"mim_id":"617798","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 53; MRD53","url":"https://www.omim.org/entry/617798"},{"mim_id":"608721","title":"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2; CAMK2N2","url":"https://www.omim.org/entry/608721"},{"mim_id":"607707","title":"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-BETA; CAMK2B","url":"https://www.omim.org/entry/607707"},{"mim_id":"605004","title":"GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B","url":"https://www.omim.org/entry/605004"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Primary cilium tip","reliability":"Approved"},{"location":"Primary cilium transition zone","reliability":"Approved"},{"location":"Principal piece","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Additional"},{"location":"Perinuclear theca","reliability":"Additional"},{"location":"Calyx","reliability":"Additional"},{"location":"Connecting piece","reliability":"Additional"},{"location":"End piece","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":104.5},{"tissue":"heart muscle","ntpm":62.4},{"tissue":"skeletal muscle","ntpm":112.2},{"tissue":"tongue","ntpm":57.4}],"url":"https://www.proteinatlas.org/search/CAMK2B"},"hgnc":{"alias_symbol":["CAM2","CAMK2","CaMKIIβ"],"prev_symbol":["CAMKB"]},"alphafold":{"accession":"Q13554","domains":[{"cath_id":"3.30.200.20","chopping":"8-92","consensus_level":"medium","plddt":91.0715,"start":8,"end":92},{"cath_id":"1.10.510.10","chopping":"93-299","consensus_level":"high","plddt":95.1984,"start":93,"end":299},{"cath_id":"3.10.450.50","chopping":"534-658","consensus_level":"high","plddt":85.6538,"start":534,"end":658}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13554","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13554-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13554-F1-predicted_aligned_error_v6.png","plddt_mean":70.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CAMK2B","jax_strain_url":"https://www.jax.org/strain/search?query=CAMK2B"},"sequence":{"accession":"Q13554","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13554.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13554/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13554"}},"corpus_meta":[{"pmid":"9768845","id":"PMC_9768845","title":"CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/beta heterooligomers to dendritic spines.","date":"1998","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/9768845","citation_count":283,"is_preprint":false},{"pmid":"22579289","id":"PMC_22579289","title":"Inverse synaptic tagging of inactive synapses via dynamic interaction of Arc/Arg3.1 with CaMKIIβ.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22579289","citation_count":253,"is_preprint":false},{"pmid":"29100089","id":"PMC_29100089","title":"De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29100089","citation_count":153,"is_preprint":false},{"pmid":"16928958","id":"PMC_16928958","title":"CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16928958","citation_count":97,"is_preprint":false},{"pmid":"27245989","id":"PMC_27245989","title":"Mechanistic study of TRPM2-Ca(2+)-CAMK2-BECN1 signaling in oxidative stress-induced autophagy inhibition.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/27245989","citation_count":91,"is_preprint":false},{"pmid":"18840684","id":"PMC_18840684","title":"CaMKIIbeta binding to stable F-actin in vivo regulates F-actin filament stability.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18840684","citation_count":84,"is_preprint":false},{"pmid":"34282994","id":"PMC_34282994","title":"CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34282994","citation_count":73,"is_preprint":false},{"pmid":"38190923","id":"PMC_38190923","title":"Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 Axes.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38190923","citation_count":71,"is_preprint":false},{"pmid":"29560374","id":"PMC_29560374","title":"De novo variants in CAMK2A and CAMK2B cause neurodevelopmental disorders.","date":"2018","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29560374","citation_count":70,"is_preprint":false},{"pmid":"21725312","id":"PMC_21725312","title":"A CaMKIIβ signaling pathway at the centrosome regulates dendrite patterning in the brain.","date":"2011","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21725312","citation_count":68,"is_preprint":false},{"pmid":"31064859","id":"PMC_31064859","title":"CAMK2-Dependent Signaling in Neurons Is Essential for Survival.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31064859","citation_count":66,"is_preprint":false},{"pmid":"33019657","id":"PMC_33019657","title":"CaMKIIβ in Neuronal Development and Plasticity: An Emerging Candidate in Brain Diseases.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33019657","citation_count":52,"is_preprint":false},{"pmid":"23785157","id":"PMC_23785157","title":"CaMKIIβ regulates oligodendrocyte maturation and CNS myelination.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23785157","citation_count":47,"is_preprint":false},{"pmid":"34303021","id":"PMC_34303021","title":"Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34303021","citation_count":42,"is_preprint":false},{"pmid":"25127391","id":"PMC_25127391","title":"Generation and behavior characterization of CaMKIIβ knockout mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25127391","citation_count":38,"is_preprint":false},{"pmid":"36194579","id":"PMC_36194579","title":"Distinct phosphorylation states of mammalian CaMKIIβ control the induction and maintenance of sleep.","date":"2022","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/36194579","citation_count":34,"is_preprint":false},{"pmid":"28607044","id":"PMC_28607044","title":"Regulation of spinogenesis in mature Purkinje cells via mGluR/PKC-mediated phosphorylation of CaMKIIβ.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28607044","citation_count":34,"is_preprint":false},{"pmid":"23600483","id":"PMC_23600483","title":"CaMKIIβ-mediated LIM-kinase activation plays a crucial role in BDNF-induced neuritogenesis.","date":"2013","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23600483","citation_count":33,"is_preprint":false},{"pmid":"1961754","id":"PMC_1961754","title":"Efficient transformation of cam2, a behavioral mutant of Paramecium tetraurelia, with the calmodulin gene.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1961754","citation_count":31,"is_preprint":false},{"pmid":"25613640","id":"PMC_25613640","title":"Capsicum annuum transcription factor WRKYa positively regulates defense response upon TMV infection and is a substrate of CaMK1 and CaMK2.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25613640","citation_count":30,"is_preprint":false},{"pmid":"34193145","id":"PMC_34193145","title":"The dysregulated expression and functional effect of CaMK2 in cancer.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/34193145","citation_count":29,"is_preprint":false},{"pmid":"29311815","id":"PMC_29311815","title":"Differential Distribution of Retinal Ca2+/Calmodulin-Dependent Kinase II (CaMKII) Isoforms Indicates CaMKII-β and -δ as Specific Elements of Electrical Synapses Made of Connexin36 (Cx36).","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29311815","citation_count":27,"is_preprint":false},{"pmid":"27244486","id":"PMC_27244486","title":"The molecular, temporal and region-specific requirements of the beta isoform of Calcium/Calmodulin-dependent protein kinase type 2 (CAMK2B) in mouse locomotion.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27244486","citation_count":25,"is_preprint":false},{"pmid":"7774714","id":"PMC_7774714","title":"Cell adhesion activity of the short cytoplasmic domain isoform of C-CAM (C-CAM2) in CHO cells.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7774714","citation_count":23,"is_preprint":false},{"pmid":"30674062","id":"PMC_30674062","title":"Effects of HIV-1 Tat on oligodendrocyte viability are mediated by CaMKIIβ-GSK3β interactions.","date":"2019","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30674062","citation_count":22,"is_preprint":false},{"pmid":"29712998","id":"PMC_29712998","title":"A novel role for CAMKIIβ in the regulation of cortical neuron migration: implications for neurodevelopmental disorders.","date":"2018","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29712998","citation_count":21,"is_preprint":false},{"pmid":"29528394","id":"PMC_29528394","title":"Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29528394","citation_count":20,"is_preprint":false},{"pmid":"17603807","id":"PMC_17603807","title":"Amphetamine sensitization elevates CaMKIIbeta mRNA.","date":"2007","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17603807","citation_count":20,"is_preprint":false},{"pmid":"21871176","id":"PMC_21871176","title":"Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells.","date":"2011","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/21871176","citation_count":19,"is_preprint":false},{"pmid":"34113835","id":"PMC_34113835","title":"Gene-environment interactions mediate stress susceptibility and resilience through the CaMKIIβ/TARPγ-8/AMPAR pathway.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34113835","citation_count":19,"is_preprint":false},{"pmid":"32875707","id":"PMC_32875707","title":"Severe intellectual disability, absence of language, epilepsy, microcephaly and progressive cerebellar atrophy related to the recurrent de novo variant p.(P139L) of the CAMK2B gene: A case report and brief review.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/32875707","citation_count":17,"is_preprint":false},{"pmid":"29151114","id":"PMC_29151114","title":"Non-canonical heterogeneous cellular distribution and co-localization of CaMKIIα and CaMKIIβ in the spinal superficial dorsal horn.","date":"2017","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/29151114","citation_count":16,"is_preprint":false},{"pmid":"26003447","id":"PMC_26003447","title":"Extracellular matrix protein reelin regulate dendritic spine density through CaMKIIβ.","date":"2015","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/26003447","citation_count":16,"is_preprint":false},{"pmid":"18562151","id":"PMC_18562151","title":"Ethanol inhibition of recombinant NMDA receptors is not altered by coexpression of CaMKII-alpha or CaMKII-beta.","date":"2008","source":"Alcohol (Fayetteville, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18562151","citation_count":15,"is_preprint":false},{"pmid":"35127542","id":"PMC_35127542","title":"Anti-Tumor Role of CAMK2B in Remodeling the Stromal Microenvironment and Inhibiting Proliferation in Papillary Renal Cell Carcinoma.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35127542","citation_count":14,"is_preprint":false},{"pmid":"25126162","id":"PMC_25126162","title":"Camk2b protects neurons from homocysteine-induced apoptosis with the involvement of HIF-1α signal pathway.","date":"2014","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25126162","citation_count":13,"is_preprint":false},{"pmid":"28181390","id":"PMC_28181390","title":"Tris (1,3-dichloro-2-propyl) phosphate induces toxicity by stimulating CaMK2 in PC12 cells.","date":"2017","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28181390","citation_count":13,"is_preprint":false},{"pmid":"37391113","id":"PMC_37391113","title":"Understanding the pathogenetic mechanisms underlying altered neuronal function associated with CAMK2B mutations.","date":"2023","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/37391113","citation_count":12,"is_preprint":false},{"pmid":"35203213","id":"PMC_35203213","title":"MiR-24-3p Conservatively Regulates Muscle Cell Proliferation and Apoptosis by Targeting Common Gene CAMK2B in Rat and Cattle.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/35203213","citation_count":12,"is_preprint":false},{"pmid":"35620293","id":"PMC_35620293","title":"Case Report: Developmental Delay and Acute Neuropsychiatric Episodes Associated With a de novo Mutation in the CAMK2B Gene (c.328G>A p.Glu110Lys).","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35620293","citation_count":12,"is_preprint":false},{"pmid":"35079728","id":"PMC_35079728","title":"CaMKIIβ knockdown decreases store-operated calcium entry in hippocampal dendritic spines.","date":"2022","source":"IBRO neuroscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/35079728","citation_count":11,"is_preprint":false},{"pmid":"29675826","id":"PMC_29675826","title":"CaMKIIβ is localized in dendritic spines as both drebrin-dependent and drebrin-independent pools.","date":"2018","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29675826","citation_count":11,"is_preprint":false},{"pmid":"32357567","id":"PMC_32357567","title":"Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32357567","citation_count":10,"is_preprint":false},{"pmid":"31555090","id":"PMC_31555090","title":"Localization of Retinal Ca2+/Calmodulin-Dependent Kinase II-β (CaMKII-β) at Bipolar Cell Gap Junctions and Cross-Reactivity of a Monoclonal Anti-CaMKII-β Antibody With Connexin36.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31555090","citation_count":10,"is_preprint":false},{"pmid":"33796307","id":"PMC_33796307","title":"A familial case of CAMK2B mutation with variable expressivity.","date":"2021","source":"SAGE open medical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/33796307","citation_count":9,"is_preprint":false},{"pmid":"36041587","id":"PMC_36041587","title":"Effects of Camk2b Overexpression and Underexpression on the Proteome of Rat Hippocampal Neurons.","date":"2022","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36041587","citation_count":8,"is_preprint":false},{"pmid":"37864744","id":"PMC_37864744","title":"Inflammatory Factor IL1α Induces Aberrant Astrocyte Proliferation in Spinal Cord Injury Through the Grin2c/Ca2+/CaMK2b Pathway.","date":"2023","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/37864744","citation_count":8,"is_preprint":false},{"pmid":"38769542","id":"PMC_38769542","title":"CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I.","date":"2024","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/38769542","citation_count":8,"is_preprint":false},{"pmid":"31317779","id":"PMC_31317779","title":"Roles of CaMKIIβ in the neurotoxicity induced by ropivacaine hydrochloride in dorsal root ganglion.","date":"2019","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31317779","citation_count":8,"is_preprint":false},{"pmid":"36543542","id":"PMC_36543542","title":"Branch point strength controls species-specific CAMK2B alternative splicing and regulates LTP.","date":"2022","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/36543542","citation_count":7,"is_preprint":false},{"pmid":"39227322","id":"PMC_39227322","title":"Precision therapy targeting CAMK2 to overcome resistance to EGFR inhibitors in FAT1 -mutated oral squamous cell carcinoma.","date":"2024","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/39227322","citation_count":7,"is_preprint":false},{"pmid":"36417808","id":"PMC_36417808","title":"GluN1 antibody causes behavioral deficits in prepulse inhibition and memory through CaMKIIβ signaling.","date":"2022","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/36417808","citation_count":7,"is_preprint":false},{"pmid":"30528771","id":"PMC_30528771","title":"Autophosphorylation of F-actin binding domain of CaMKIIβ is required for fear learning.","date":"2018","source":"Neurobiology of learning and memory","url":"https://pubmed.ncbi.nlm.nih.gov/30528771","citation_count":7,"is_preprint":false},{"pmid":"33205074","id":"PMC_33205074","title":"A Small-Molecule Approach to Restore a Slow-Oxidative Phenotype and Defective CaMKIIβ Signaling in Limb Girdle Muscular Dystrophy.","date":"2020","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33205074","citation_count":7,"is_preprint":false},{"pmid":"39631163","id":"PMC_39631163","title":"CAMK2; four genes, one syndrome? Delineation of genotype-phenotype correlations.","date":"2024","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39631163","citation_count":6,"is_preprint":false},{"pmid":"35043465","id":"PMC_35043465","title":"Elucidation of pathological mechanism caused by human disease mutation in CaMKIIβ.","date":"2022","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/35043465","citation_count":6,"is_preprint":false},{"pmid":"31435871","id":"PMC_31435871","title":"Hypergravity-induced plastic alteration of the vestibulo-sympathetic reflex involves decrease in responsiveness of CAMK2-expressing neurons in the vestibular nuclear complex.","date":"2019","source":"The journal of physiological sciences : JPS","url":"https://pubmed.ncbi.nlm.nih.gov/31435871","citation_count":6,"is_preprint":false},{"pmid":"37686242","id":"PMC_37686242","title":"ERK1/2-Dependent Phosphorylation of GABAB1(S867/T872), Controlled by CaMKIIβ, Is Required for GABAB Receptor Degradation under Physiological and Pathological Conditions.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37686242","citation_count":6,"is_preprint":false},{"pmid":"39984440","id":"PMC_39984440","title":"Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39984440","citation_count":5,"is_preprint":false},{"pmid":"38490509","id":"PMC_38490509","title":"Targeting CAMK2N1/CAMK2 inhibits invasion, migration and angiogenesis of non-small cell lung cancer by promoting autophagy and apoptosis via AKT/mTOR signaling pathway.","date":"2024","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/38490509","citation_count":5,"is_preprint":false},{"pmid":"39862102","id":"PMC_39862102","title":"Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway.","date":"2025","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/39862102","citation_count":5,"is_preprint":false},{"pmid":"37681454","id":"PMC_37681454","title":"Vascular endothelial growth factor B regulates insulin secretion in β cells of type 2 diabetes mellitus mice via PLCγ and the IP3R‑evoked Ca2+/CaMK2 signaling pathway.","date":"2023","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/37681454","citation_count":4,"is_preprint":false},{"pmid":"38161415","id":"PMC_38161415","title":"Glucose restriction enhances oxidative fiber formation: A multi-omic signal network involving AMPK and CaMK2.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38161415","citation_count":4,"is_preprint":false},{"pmid":"38501502","id":"PMC_38501502","title":"Ca2+/CaM dependent protein kinase II (CaMKII)α and CaMKIIβ hub domains adopt distinct oligomeric states and stabilities.","date":"2024","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/38501502","citation_count":4,"is_preprint":false},{"pmid":"25031715","id":"PMC_25031715","title":"Alternative splicing in the variable domain of CaMKIIβ affects the level of F-actin association in developing neurons.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25031715","citation_count":4,"is_preprint":false},{"pmid":"41050075","id":"PMC_41050075","title":"CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway.","date":"2025","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/41050075","citation_count":3,"is_preprint":false},{"pmid":"40645772","id":"PMC_40645772","title":"CaMKIIβ-mediated Phosphorylation Enhances Protein Stability of Spastin to Promote Neurite Outgrowth.","date":"2025","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40645772","citation_count":3,"is_preprint":false},{"pmid":"27278128","id":"PMC_27278128","title":"Phorbol ester-mediated re-expression of endogenous LAT adapter in J.CaM2 cells: a model for dissecting drivers and blockers of LAT transcription.","date":"2016","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27278128","citation_count":3,"is_preprint":false},{"pmid":"39919714","id":"PMC_39919714","title":"CaMKIIβ Ca2+ptures ER signals to initiate autophagosome biogenesis.","date":"2025","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/39919714","citation_count":3,"is_preprint":false},{"pmid":"40683492","id":"PMC_40683492","title":"The m6A reader IGF2BP3 facilitates myogenesis by activating the CAMK2B-MEF2C axis.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40683492","citation_count":2,"is_preprint":false},{"pmid":"40272685","id":"PMC_40272685","title":"The Protective Effect of Annexin A1 on Autophagy Via the CAMK2/BECN1 Signaling Pathway in PC12 Cells Stimulated with H2O2.","date":"2025","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/40272685","citation_count":2,"is_preprint":false},{"pmid":"37659612","id":"PMC_37659612","title":"Super-resolution imaging reveals the relationship between CaMKIIβ and drebrin within dendritic spines.","date":"2023","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/37659612","citation_count":2,"is_preprint":false},{"pmid":"37734707","id":"PMC_37734707","title":"A CAMK2B variant associated with tetralogy of Fallot, developmental delay, and growth retardation.","date":"2023","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37734707","citation_count":1,"is_preprint":false},{"pmid":"38405732","id":"PMC_38405732","title":"Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically \"actionable\" signalling axis in triple negative breast cancer.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38405732","citation_count":1,"is_preprint":false},{"pmid":"34922202","id":"PMC_34922202","title":"Adeno-associated virus-mediated expression of an inactive CaMKIIβ mutant enhances muscle mass and strength in mice.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/34922202","citation_count":1,"is_preprint":false},{"pmid":"41638654","id":"PMC_41638654","title":"CAMK2 Expression and Its Regulation on Testosterone Synthesis in Mouse Testis.","date":"2026","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/41638654","citation_count":0,"is_preprint":false},{"pmid":"39113374","id":"PMC_39113374","title":"Severe Developmental Delay and Behavior Abnormalities in a Patient with De Novo CAMK2B Mutation: A Case Report and Literature Review.","date":"2024","source":"Annals of Indian Academy of Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/39113374","citation_count":0,"is_preprint":false},{"pmid":"41740964","id":"PMC_41740964","title":"Phosphoproteomic Analysis of Cortical Tissue from Mice Lacking Both CaMKIIα and CaMKIIβ Identifies Novel In Vivo Substrates.","date":"2026","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/41740964","citation_count":0,"is_preprint":false},{"pmid":"39459529","id":"PMC_39459529","title":"Hypoxia Modulates Sodium Chloride Co-transporter via CaMKII-β Pathway: An In Vitro Study with mDCT15 Cells.","date":"2024","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/39459529","citation_count":0,"is_preprint":false},{"pmid":"41984532","id":"PMC_41984532","title":"CaMKIIβ insufficiency disrupts cortical networks, producing aberrant low-gamma oscillations and seizure susceptibility.","date":"2026","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/41984532","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":40731,"output_tokens":8555,"usd":0.125259,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18673,"output_tokens":7124,"usd":0.135733,"stage2_stop_reason":"end_turn"},"total_usd":0.260992,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"CaMKIIβ (but not CaMKIIα) binds to F-actin in dendritic spines and cell cortex, functioning as a targeting module that localizes CaMKIIα/β heterooligomers to synaptic and cytoskeletal sites. When co-expressed, CaMKIIα and CaMKIIβ form large heterooligomers, and a small fraction of CaMKIIβ is sufficient to dock the predominant CaMKIIα to the actin cytoskeleton.\",\n      \"method\": \"GFP-tagged CaMKII isoform live imaging in neurons; co-expression heterooligomer analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct live-cell imaging with GFP fusions, replicated concept across multiple subsequent labs\",\n      \"pmids\": [\"9768845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CaMKIIβ association with the F-actin cytoskeleton requires inclusion of alternatively spliced exon v1; the neonatal variant CaMKIIβe (lacking exon v1) fails to associate with F-actin. CaMKIIβ (but not CaMKIIα) bundles F-actin filaments in vitro and can phosphorylate actin in vitro even by basal (unstimulated) activity in the absence of Ca2+/CaM.\",\n      \"method\": \"Alternative splicing analysis with deletion constructs; F-actin bundling in vitro assay; in-cell F-actin co-localization; in vitro kinase assay on actin\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of F-actin bundling and phosphorylation plus cellular localization with multiple isoform constructs; findings replicated in subsequent papers\",\n      \"pmids\": [\"16928958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CaMKIIβ binds preferentially to stable (vs. dynamic) F-actin in embryonic cortical neurons. CaMKIIβ binding to F-actin is disrupted by Ca2+/calmodulin binding or by high phosphorylation, but not by kinase inactivity. CaMKIIβ over-expression increased F-actin-rich structures, while disruption of its F-actin binding reduced them, indicating CaMKIIβ binding to stable F-actin maintains polymerized F-actin in vivo.\",\n      \"method\": \"FRAP of GFP-CaMKIIβ in CaMKIIα-free embryonic cortical neurons; pharmacological F-actin stabilization/destabilization; deletion mutant analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — FRAP with functional rescue and multiple mutant constructs in a clean CaMKIIα-free system\",\n      \"pmids\": [\"18840684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CaMKIIβ operates at the centrosome (localized there by the targeting protein PCM1) in a CaMKIIα-independent manner to drive dendrite retraction and pruning. CaMKIIβ phosphorylates the E3 ubiquitin ligase substrate Cdc20 at Ser51, inducing Cdc20 dispersion from the centrosome, inhibiting centrosomal Cdc20-APC activity, and triggering the transition from dendrite growth to retraction.\",\n      \"method\": \"Knockdown in primary rat neurons and in vivo in rat cerebellar cortex; identification of PCM1 as centrosomal targeting partner; in vitro kinase assay identifying Cdc20 Ser51 as CaMKIIβ phosphorylation site; Cdc20-APC activity assay\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay with defined phosphosite, in vivo knockdown, and identification of upstream targeting partner PCM1; multiple orthogonal methods\",\n      \"pmids\": [\"21725312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Arc/Arg3.1 interacts with high affinity with CaMKIIβ that is not bound to calmodulin. Arc accumulates at inactive synapses via this interaction, leading to AMPA-R (GluA1) endocytosis. Loss of CaMKIIβ in vitro or in vivo abolished Arc upregulation at silenced synapses, establishing CaMKIIβ as the targeting receptor for Arc in 'inverse synaptic tagging'.\",\n      \"method\": \"Co-immunoprecipitation; in vivo CaMKIIβ knockout; immunofluorescence for surface GluA1; synaptic activity manipulations\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding experiments with genetic KO validation in vitro and in vivo, multiple orthogonal readouts\",\n      \"pmids\": [\"22579289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CaMKIIβ is critical for the morphological maturation of differentiating oligodendrocytes and regulates myelin thickness in vivo. CaMKIIβ has an actin-cytoskeleton-stabilizing role in oligodendrocytes, and its in vivo function in myelin thickness may be mediated by non-kinase-catalytic (structural) activity, as shown using Camk2b knockout and Camk2b(A303R) kinase-dead mutant mice.\",\n      \"method\": \"In vitro oligodendrocyte culture with CaMKIIβ manipulation; Camk2b knockout mice; Camk2b(A303R) kinase-dead knock-in mice; myelin thickness measurement\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (KO and kinase-dead knock-in) with in vitro and in vivo phenotypic readouts\",\n      \"pmids\": [\"23785157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CaMKIIβ (but not CaMKIIα) is required for BDNF-induced neuritogenesis. CaMKIIβ phosphorylates LIM-kinase 1 (LIMK1) at Thr-508 in the kinase domain, activating LIMK1's cofilin-phosphorylating activity, which in turn drives actin cytoskeletal reorganization and primary neurite formation.\",\n      \"method\": \"CaMKIIβ knockdown in cortical neurons; in vitro kinase assay identifying LIMK1 Thr-508 phosphorylation; kinase-dead LIMK1 mutant rescue; pharmacological CaMK inhibition\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with defined phosphosite plus cellular knockdown and rescue, single lab but two orthogonal methods\",\n      \"pmids\": [\"23600483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CaMKIIβ promotes spine formation and elongation in cerebellar Purkinje cells through its F-actin bundling activity. Activation of group I mGluR (but not AMPAR) triggers PKC-mediated phosphorylation of CaMKIIβ, causing dissociation of the CaMKIIβ/F-actin complex. Defective PKC-mediated CaMKIIβ phosphorylation promotes excess F-actin bundling and leads to abnormally numerous and elongated spines.\",\n      \"method\": \"Purkinje cell spine morphology analysis; pharmacological mGluR activation; PKC inhibition; CaMKIIβ phosphorylation assay; IP3R1-deficient mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mouse model combined with pharmacological dissection of mGluR/PKC pathway and direct measurement of CaMKIIβ/F-actin complex\",\n      \"pmids\": [\"28607044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Normal locomotion requires Ca2+/calmodulin-mediated activation of CAMK2B, but CAMK2B autonomous (Ca2+-independent) activity is largely dispensable. Severe locomotion deficits in Camk2b−/− mice are largely of developmental origin, as adult-onset deletion causes only mild deficits. These deficits cannot be attributed to a single brain area (cerebellum, striatum, or forebrain).\",\n      \"method\": \"Conditional Camk2b knockout (Camk2b(f/f)); Camk2b(T287A) knock-in (autonomous activity block); temporal and region-specific Cre-mediated deletion; behavioral locomotion assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models with temporal and regional specificity; multiple orthogonal behavioral readouts\",\n      \"pmids\": [\"27244486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"De novo mutations in CAMK2B that alter auto-phosphorylation at Thr287 (either decreasing or increasing it) also impair neuronal migration in vitro and in vivo, establishing that tightly regulated CAMK2B auto-phosphorylation is required for normal neuronal migration and brain development.\",\n      \"method\": \"Whole-exome sequencing; CAMK2 auto-phosphorylation assays in cell lines; neuronal migration assays in vitro and in vivo\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent human mutations tested with direct phosphorylation assays and neuronal migration functional assay\",\n      \"pmids\": [\"29100089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CaMKIIβ controls radial migration of cortical projection neurons through its actin-binding and -bundling activities; knockdown accelerates migration while overexpression inhibits it. A fine-tuned balance between CaMKIIβ and cofilin activities is necessary for proper neuronal migration, placing CaMKIIβ upstream of actin dynamics in cortical neuron locomotion.\",\n      \"method\": \"In utero electroporation with CaMKIIβ knockdown/overexpression and actin-binding domain mutants; analysis of multipolar-bipolar transition and locomotion in cortical plate\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo in utero electroporation with domain-specific mutants and multiple cellular phenotype readouts\",\n      \"pmids\": [\"29712998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Autophosphorylation at the F-actin binding domain of CaMKIIβ is required for fear learning. Phosphoblock mutations in the actin-binding domain (knock-in mice) impair contextual and cued fear conditioning, demonstrating that proper regulation of CaMKIIβ–F-actin interaction is important for learning and memory.\",\n      \"method\": \"CaMKIIβ F-actin binding domain phosphoblock knock-in mice; contextual and cued fear conditioning behavioral tests\",\n      \"journal\": \"Neurobiology of learning and memory\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knock-in mouse model with defined phosphosite mutation and direct behavioral phenotype\",\n      \"pmids\": [\"30528771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CaMKIIβ is localized in dendritic spines as both drebrin-dependent and drebrin-independent pools. Drebrin knockdown causes diffuse localization of CaMKIIβ and increases the stable CaMKIIβ fraction. NMDA receptor activation releases CaMKIIβ from the drebrin-binding F-actin complex, shifting CaMKIIβ association to the PSD.\",\n      \"method\": \"Yeast two-hybrid identification of drebrin–CaMKIIβ interaction; FRAP analysis in rat hippocampal neurons; drebrin knockdown; NMDA receptor activation\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus FRAP in neurons plus genetic knockdown, multiple orthogonal methods\",\n      \"pmids\": [\"29675826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Both Ca2+-dependent and Ca2+-independent (autonomous) activity of CAMK2 are essential for survival. Combined loss of CAMK2A and CAMK2B abolishes LTP but does not affect synaptic transmission or the biochemical composition of the postsynaptic density, demonstrating that CAMK2 signaling is required for postnatal development and mature brain function beyond PSD structural organization.\",\n      \"method\": \"Germline and adult-inducible Camk2a/Camk2b double knockout mice; Ca2+-dependent/autonomous activity mutant mice; LTP electrophysiology; PSD biochemical fractionation; brain morphology\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models with activity-specific mutations; multiple orthogonal phenotypic and biochemical readouts\",\n      \"pmids\": [\"31064859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CaMKIIβ interacts with GSK3β and opposes its activity in oligodendrocytes. HIV-1 Tat increases CaMKIIβ activity in oligodendrocytes; pharmacological or genetic inhibition of CaMKIIβ increases GSK3β activity and promotes death in mature oligodendrocytes treated with Tat, showing that CaMKIIβ–GSK3β interaction determines oligodendrocyte viability.\",\n      \"method\": \"CaMKII inhibitor (KN-93) treatment; CaMKIIβ knockdown in oligodendrocyte cultures; GSK3β activity assay; cell viability assays; in vivo Tat transgenic mice\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown and pharmacological inhibition in vitro plus in vivo model, single lab\",\n      \"pmids\": [\"30674062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CAMK2 activation disrupts adipocyte insulin signaling and lowers insulin receptor levels, contributes to lipolysis and TNFα-induced inflammation. Adipocyte-specific CAMK2 deletion in obese mice improved glucose intolerance and insulin resistance, establishing CAMK2 as a regulator of adipocyte metabolic function.\",\n      \"method\": \"Conditional adipocyte-specific CAMK2 knockout mice; in vitro differentiated adipocytes; insulin signaling analysis; glucose and insulin tolerance tests\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional genetic knockout with in vivo metabolic phenotyping and in vitro mechanistic follow-up; multiple orthogonal readouts\",\n      \"pmids\": [\"34303021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CAMK2/CaMKII (including the β isoform) phosphorylates MLKL in a RIPK3-independent manner during short-term nutrient starvation, facilitating autophagic flux by promoting autophagosome maturation and fusion with lysosomes, independent of necroptosis.\",\n      \"method\": \"Genetic knockdown/knockout of CAMK2 and MLKL in multiple cell lines; pharmacological inhibition; LC3-II and p62 flux assays; pHluorin-mKate2-LC3 autolysosome incorporation assay\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic and pharmacological approaches across multiple cell lines with direct autophagic flux readouts\",\n      \"pmids\": [\"34282994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CaMKIIβ-mediated phosphorylation of TARPγ-8 enhances GluA1 AMPA receptor expression at postsynaptic sites in the ventral hippocampus, enabling stress resilience; this CaMKIIβ/TARPγ-8/AMPAR pathway mediates gene-environment interactions controlling behavioral susceptibility and resilience to chronic stress.\",\n      \"method\": \"CaMKIIβ activity manipulation in vivo in ventral hippocampus; phosphorylation assays; GluA1 surface expression measurement; behavioral stress paradigms in GxE mouse models\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo manipulation with phosphorylation and receptor expression readouts, single lab\",\n      \"pmids\": [\"34113835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Distinct phosphorylation states of CaMKIIβ differentially control sleep induction versus sleep maintenance: a mutant mimicking constitutive-active auto-phosphorylation promotes wakefulness-to-sleep transition, while mutants mimicking subsequent multisite auto-phosphorylation suppress sleep-to-wakefulness transition. Sleep regulation depends on CaMKIIβ kinase activity.\",\n      \"method\": \"Camk2b knockout mice; CaMKIIβ activation/inhibition in mice; phosphomimetic and phosphoblock CaMKIIβ mutants; EEG sleep duration/state analysis\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple phosphorylation-state mutants with in vivo EEG sleep phenotyping\",\n      \"pmids\": [\"36194579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Primate-specific CAMK2B alternative splice isoforms (generated through evolutionarily weakened branch point sequences) show altered kinetic properties and changed substrate specificity. Introducing a weaker human branch point sequence into mouse Camk2b via CRISPR/Cas9 strongly alters splicing in brain and severely impairs LTP at CA3-CA1 synapses.\",\n      \"method\": \"Identification of primate-specific CAMK2B isoforms; in vitro kinase assays of splice isoforms; CRISPR/Cas9 knock-in of human branch point into mouse; LTP electrophysiology in hippocampal slices\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assays plus CRISPR knock-in mouse model with electrophysiological functional validation\",\n      \"pmids\": [\"36543542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CaMKIIβ knockdown reduces store-operated calcium entry (nSOCE) amplitude in dendritic spines of hippocampal neurons and causes mushroom spine loss, linking CaMKIIβ to regulation of spine calcium homeostasis and structural maintenance.\",\n      \"method\": \"CaMKIIβ knockdown by siRNA in primary hippocampal neurons; calcium imaging for nSOCE; spine morphology analysis; pharmacological CaMKII inhibition (KN-62)\",\n      \"journal\": \"IBRO neuroscience reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown plus pharmacological inhibition with calcium imaging readout, single lab\",\n      \"pmids\": [\"35079728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Super-resolution STORM imaging shows CaMKIIβ co-localizes with drebrin in the core region of dendritic spines; NMDA receptor activation dissociates CaMKIIβ from drebrin in the core region. Drebrin knockdown decreases CaMKIIβ in the core but not the submembrane region, establishing drebrin-dependent clustering of CaMKIIβ in the spine core as a resting-state standby arrangement.\",\n      \"method\": \"STORM super-resolution microscopy; NMDA receptor activation; drebrin knockdown in hippocampal neurons\",\n      \"journal\": \"Neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution imaging with genetic knockdown, single lab\",\n      \"pmids\": [\"37659612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CaMKIIβ activates ERK1/2, which then phosphorylates GABAB1 at S867 and T872, triggering lysosomal degradation of GABAB receptors. Mutational inactivation of T872 or blocking ERK1/2 prevents receptor degradation, revealing that CaMKIIβ does not directly phosphorylate S867 but instead acts upstream of ERK1/2 in the GABAB receptor degradation pathway.\",\n      \"method\": \"Site-directed mutagenesis of GABAB1 phosphosites; ERK1/2 inhibition; CaMKIIβ manipulation; receptor degradation assays in cultured neurons under physiological and ischemic conditions\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — site-directed mutagenesis of defined phosphosites combined with epistasis (CaMKIIβ → ERK1/2 → GABAB1) in neurons\",\n      \"pmids\": [\"37686242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CaMKIIβ hub domains adopt both 14-mer and 16-mer oligomeric assemblies that coexist in solution. CaMKIIβ hub is less stable than CaMKIIα hub, with larger oligomers being more stable. A dimeric CaMKIIβ hub unit created by rational mutagenesis is significantly less stable than the oligomer, and both hubs populate an intermediate during unfolding.\",\n      \"method\": \"X-ray crystallography (3.1 Å 14-mer and 3.4 Å 16-mer crystal structures); mass photometry; temperature denaturation; rational mutagenesis to create dimer\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — two crystal structures plus mass photometry and biophysical stability analyses in single study\",\n      \"pmids\": [\"38501502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I. CaMKIIβ/βM overexpression normalizes endplate fragmentation and corrects aberrant synaptic gene expression (including abnormal HDAC4 accumulation) in innervated Mbnl1ΔE3/ΔE3 muscle, placing CaMKIIβ upstream of HDAC4-regulated synaptic gene programs.\",\n      \"method\": \"HSALR and Mbnl1ΔE3/ΔE3 DM1 mouse models; AAV-mediated CaMKIIβ overexpression; endplate morphology; synaptic gene expression; HDAC4 immunostaining; AChR turnover assays\",\n      \"journal\": \"Skeletal muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two genetic DM1 mouse models with rescue by CaMKIIβ overexpression and multiple molecular and morphological readouts\",\n      \"pmids\": [\"38769542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CaMKIIβ interacts with and phosphorylates spastin at Ser233 and Ser562, reducing its polyubiquitination and suppressing proteasomal degradation, thereby increasing spastin protein stability, enhancing its microtubule-severing activity, and promoting neurite outgrowth in hippocampal neurons.\",\n      \"method\": \"Co-IP identifying CaMKIIβ–spastin interaction; in vitro kinase assay mapping Ser233/Ser562 phosphosites; ubiquitination assays; proteasomal degradation assays; neurite outgrowth analysis; mEPSC electrophysiology; behavioral tests (Y-maze, Morris water maze)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay with defined phosphosites, ubiquitination mechanistic follow-up, and in vivo behavioral validation; multiple orthogonal methods\",\n      \"pmids\": [\"40645772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Calpain 3 (CAPN3) colocalizes with CaMKIIβ at the muscle triad; CAPN3 knockout reduces triad integrity and blunts CaMKIIβ signaling, impairing transcriptional activation of myofibrillar and oxidative metabolism genes in response to exercise and during muscle reloading after atrophy. CaMKIIβ signaling is required for induction of HSP70 and the inflammatory response needed for muscle recovery.\",\n      \"method\": \"CAPN3 knockout mice; hindlimb unloading/reloading model; CaMKIIβ activation measurement; RNA-sequencing; HSP70 expression; immune cell infiltration analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with RNA-seq and multiple molecular readouts, single lab\",\n      \"pmids\": [\"29528394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CaMKIIβ specifically (among the four CaMKII isoforms) enhances the surface expression and channel activity of the Ca2+-activated chloride channel ANO1 in glioblastoma cells. Gene silencing of CaMKIIβ suppresses ANO1 surface expression and channel activity and reduces migration and invasion of glioblastoma cells.\",\n      \"method\": \"KN-93 pharmacological inhibition; CaMKIIβ siRNA knockdown; heterologous expression of individual CaMKII isoforms; ANO1 surface expression assay; patch-clamp electrophysiology; migration/invasion assays\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific knockdown and heterologous expression with electrophysiological and cell biological readouts, single lab\",\n      \"pmids\": [\"32357567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ERK1/2 is identified as an important linker downstream of CaMKIIβ affecting synaptic protein expression in hippocampal neurons; CaMKIIβ overexpression or underexpression leads to different profiles of synaptic protein changes, with Mapk3 (ERK1) as a candidate target linking CaMKIIβ dysregulation to synaptogenesis.\",\n      \"method\": \"Lentiviral CaMKIIβ overexpression and knockdown in rat hippocampal neurons; iTRAQ-based quantitative proteomics; immunoblot validation; protein interaction network analysis\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — proteomics-based association with immunoblot confirmation, no direct phosphorylation or interaction experiment for CaMKIIβ→ERK, single lab\",\n      \"pmids\": [\"36041587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Alternative splicing of the CaMKIIβ variable region determines F-actin association in developing neurons: exon E1 is required for F-actin association, while exon E4 assists but is not required. CaMKIIβ isoforms lacking E1 (βe and β'e) do not associate with F-actin microspikes in embryonic cortical neurons.\",\n      \"method\": \"Expression of CaMKIIβ splice variants with and without E1/E4 in E18 rat cortical neurons; co-localization with F-actin microspike structures\",\n      \"journal\": \"International journal of clinical and experimental pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell biological analysis of multiple defined splice variants in a clean CaMKIIα-free system, consistent with prior in vitro work\",\n      \"pmids\": [\"25031715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Phosphoproteomic analysis of CaMKIIα/CaMKIIβ double-knockout cortical tissue identified 130 proteins with reduced phosphorylation, including 113 not previously known as CaMKII substrates, and provided new in vivo data on the CaMKII substrate consensus sequence.\",\n      \"method\": \"Inducible Camk2a/Camk2b double KO mice; mass spectrometry-based phosphoproteomics; comparison of 5622 phosphopeptides from 2080 proteins\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased in vivo phosphoproteomic screen in double KO vs WT; rigorous genetic model but no direct phosphorylation validation for individual substrates in this study\",\n      \"pmids\": [\"41740964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CaMKIIβ hub domain crystal structures reveal coexisting 14-mer and 16-mer assemblies. The CaMKIIβ hub is significantly less thermodynamically stable than the CaMKIIα hub, and larger oligomers are more stable than smaller ones.\",\n      \"method\": \"X-ray crystallography at 3.1 Å (14-mer) and 3.4 Å (16-mer); mass photometry; temperature denaturation experiments; rational mutagenesis to produce dimer\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — two crystal structures from the same crystallization drop plus orthogonal biophysical analyses; single lab but rigorous multi-method approach\",\n      \"pmids\": [\"38501502\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CaMKIIβ is a Ca2+/calmodulin-activated serine/threonine kinase that is uniquely distinguished from CaMKIIα by an alternatively spliced variable domain (requiring exon v1) that enables direct binding and bundling of F-actin, targeting heterooligomeric CaMKIIα/β complexes to dendritic spines; activation by Ca2+/calmodulin or autophosphorylation releases CaMKIIβ from the actin cytoskeleton, creating a regulated structural-to-signaling switch that controls spine morphology, actin stability, LTP, fear learning, neuronal migration, dendrite patterning (via centrosomal phosphorylation of Cdc20-APC), Arc-mediated inverse synaptic tagging, LIMK1 activation, GABAB receptor degradation (via ERK1/2), spastin stabilization, oligodendrocyte maturation, sleep regulation, and autophagy, while its hub domain assembles into coexisting 14-mer and 16-mer oligomers that are distinctly less stable than those of CaMKIIα.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CaMKII\\u03b2 is a Ca2+/calmodulin-activated serine/threonine kinase that doubles as a structural actin-organizing protein, coupling calcium signaling to cytoskeletal dynamics in neurons [#0, #1]. Its distinguishing feature is an alternatively spliced variable domain (requiring exon v1/E1) that confers direct F-actin binding and bundling not shared by CaMKII\\u03b1; CaMKII\\u03b2 thereby targets CaMKII\\u03b1/\\u03b2 heterooligomers to dendritic spines and the cell cortex, and isoforms lacking this exon fail to associate with F-actin [#0, #1, #29]. CaMKII\\u03b2 binds preferentially to stable F-actin and maintains polymerized actin in vivo, an association released by Ca2+/calmodulin binding, autophosphorylation, or PKC-mediated phosphorylation, creating a regulated structural-to-signaling switch that governs spine formation, elongation, and maintenance [#2, #7, #11, #20]. Through this actin-binding/bundling activity CaMKII\\u03b2 controls radial migration of cortical neurons in balance with cofilin, and tightly regulated Thr287 autophosphorylation\\u2014both gains and losses\\u2014impairs neuronal migration and underlies a neurodevelopmental disorder caused by de novo CAMK2B mutations [#9, #10]. As a kinase, CaMKII\\u03b2 phosphorylates defined substrates to remodel the cytoskeleton and synapse: LIMK1 at Thr508 to drive BDNF-induced neuritogenesis [#6], Cdc20 at Ser51 at the PCM1-targeted centrosome to inhibit Cdc20-APC and trigger dendrite retraction [#3], and spastin at Ser233/Ser562 to stabilize it against proteasomal degradation and promote neurite outgrowth [#25]. It also acts non-catalytically and through partner recruitment\\u2014serving as the calmodulin-free receptor for Arc in inverse synaptic tagging [#4], scaffolding with drebrin in the spine core as a resting-state arrangement released by NMDA receptor activation [#12, #21], and acting upstream of ERK1/2 to drive GABAB receptor lysosomal degradation [#22]. CaMKII\\u03b2 activity is required for LTP, fear learning, locomotion, and sleep regulation [#11, #13, #18, #19], and beyond the nervous system it regulates autophagic flux via MLKL phosphorylation [#16], adipocyte insulin signaling [#15], and oligodendrocyte maturation and viability through actin stabilization and GSK3\\u03b2 antagonism [#5, #14]. Structurally, the CaMKII\\u03b2 hub domain assembles into coexisting 14-mer and 16-mer oligomers that are less stable than those of CaMKII\\u03b1 [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that CaMKII\\u03b2, unlike CaMKII\\u03b1, binds F-actin and acts as a targeting module that docks CaMKII heterooligomers to dendritic spines, defining a non-catalytic localization function distinct from kinase activity.\",\n      \"evidence\": \"GFP-tagged CaMKII isoform live imaging and co-expression heterooligomer analysis in neurons\",\n      \"pmids\": [\"9768845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the structural determinant within CaMKII\\u03b2 responsible for F-actin binding\", \"Did not establish how the interaction is regulated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified the alternatively spliced exon v1 as the determinant of F-actin association and showed CaMKII\\u03b2 bundles and phosphorylates actin, linking the splice-defined domain to both structural and enzymatic actions on the cytoskeleton.\",\n      \"evidence\": \"Splice deletion constructs, in vitro F-actin bundling, in-cell co-localization, and in vitro kinase assay on actin\",\n      \"pmids\": [\"16928958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of actin phosphorylation in vivo not resolved\", \"Did not address regulation by Ca2+/CaM in cells\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showed CaMKII\\u03b2 selectively binds stable F-actin and maintains polymerized actin, and that Ca2+/calmodulin or high phosphorylation (not kinase inactivity) releases it, defining the regulated structural-to-signaling switch.\",\n      \"evidence\": \"FRAP of GFP-CaMKII\\u03b2 in CaMKII\\u03b1-free cortical neurons with pharmacological actin manipulation and deletion mutants\",\n      \"pmids\": [\"18840684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphosites controlling release not mapped here\", \"Downstream effects of actin stabilization on synaptic function not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined a CaMKII\\u03b1-independent centrosomal function: CaMKII\\u03b2 phosphorylates Cdc20 at Ser51 to inhibit Cdc20-APC and drive dendrite retraction, extending CaMKII\\u03b2 substrate biology beyond actin.\",\n      \"evidence\": \"Neuronal knockdown in vitro and in vivo, PCM1 targeting identification, in vitro kinase assay mapping Cdc20 Ser51, and Cdc20-APC activity assay\",\n      \"pmids\": [\"21725312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CaMKII\\u03b2 activity at the centrosome is triggered remains unclear\", \"Relationship between centrosomal and spine pools not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established CaMKII\\u03b2 as the calmodulin-free targeting receptor for Arc, mechanistically linking synaptic inactivity to AMPA receptor endocytosis in inverse synaptic tagging.\",\n      \"evidence\": \"Co-immunoprecipitation, CaMKII\\u03b2 knockout in vitro and in vivo, surface GluA1 immunofluorescence, and synaptic activity manipulation\",\n      \"pmids\": [\"22579289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the calmodulin-state-dependent Arc binding not resolved\", \"Whether kinase activity is involved not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified LIMK1 Thr508 as a CaMKII\\u03b2 substrate driving BDNF-induced neuritogenesis and showed CaMKII\\u03b2 (not \\u03b1) is required, connecting CaMKII\\u03b2 to the cofilin/actin reorganization pathway.\",\n      \"evidence\": \"CaMKII\\u03b2 knockdown in cortical neurons, in vitro kinase assay, and kinase-dead LIMK1 rescue\",\n      \"pmids\": [\"23600483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo requirement for LIMK1 phosphorylation by CaMKII\\u03b2 not tested\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated CaMKII\\u03b2 is required for oligodendrocyte maturation and myelin thickness, and that this function may be largely non-catalytic, broadening its role beyond neurons and beyond kinase activity.\",\n      \"evidence\": \"Oligodendrocyte cultures, Camk2b knockout mice, and Camk2b(A303R) kinase-dead knock-in mice with myelin thickness measurement\",\n      \"pmids\": [\"23785157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The structural mechanism mediating myelin thickness not defined\", \"Partner proteins in oligodendrocytes not identified here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Distinguished developmental from acute requirements: Ca2+/calmodulin activation (not autonomous activity) is needed for locomotion, and deficits arise developmentally and are not localized to one brain region.\",\n      \"evidence\": \"Conditional Camk2b knockout, Camk2b(T287A) autonomy-block knock-in, and temporal/regional Cre deletion with behavioral assays\",\n      \"pmids\": [\"27244486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific developmental circuit affected not pinpointed\", \"Molecular substrates underlying locomotion not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established that tightly regulated Thr287 autophosphorylation is essential for neuronal migration and brain development, linking de novo CAMK2B mutations to a neurodevelopmental disorder.\",\n      \"evidence\": \"Whole-exome sequencing, autophosphorylation assays, and neuronal migration assays in vitro and in vivo\",\n      \"pmids\": [\"29100089\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream migration substrates of CaMKII\\u03b2 not defined here\", \"Genotype-phenotype correlations across patients not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed CaMKII\\u03b2 controls cortical radial migration through actin binding/bundling in balance with cofilin, and that F-actin-binding-domain autophosphorylation is required for fear learning, tying its structural switch directly to behavior.\",\n      \"evidence\": \"In utero electroporation with domain mutants; F-actin binding domain phosphoblock knock-in mice with fear conditioning\",\n      \"pmids\": [\"29712998\", \"30528771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How migration and learning phenotypes mechanistically connect not defined\", \"Precise kinetics of the actin-binding switch in vivo unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified drebrin as a CaMKII\\u03b2 partner organizing a resting-state pool in the spine core that is released by NMDA receptor activation, defining how CaMKII\\u03b2 is positioned for activity-dependent redistribution.\",\n      \"evidence\": \"Yeast two-hybrid, FRAP in hippocampal neurons, drebrin knockdown, and NMDA receptor activation (later refined by STORM imaging)\",\n      \"pmids\": [\"29675826\", \"37659612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional output of drebrin-dependent versus -independent pools not fully separated\", \"Whether drebrin binding requires kinase activity not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated both Ca2+-dependent and autonomous CaMKII activity are essential for survival and LTP without altering PSD composition, separating CaMKII signaling from structural scaffolding of the postsynaptic density.\",\n      \"evidence\": \"Germline and adult-inducible Camk2a/Camk2b double knockouts, activity mutant mice, LTP electrophysiology, and PSD fractionation\",\n      \"pmids\": [\"31064859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Isoform-specific contributions of CaMKII\\u03b2 within the double KO not isolated\", \"Substrates mediating survival not identified here\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed CaMKII\\u03b2 antagonizes GSK3\\u03b2 to determine oligodendrocyte viability in an HIV-1 Tat model, adding a viability-control axis to CaMKII\\u03b2 oligodendrocyte biology.\",\n      \"evidence\": \"KN-93 inhibition and CaMKII\\u03b2 knockdown in oligodendrocyte cultures, GSK3\\u03b2 activity and viability assays, and Tat transgenic mice\",\n      \"pmids\": [\"30674062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CaMKII\\u03b2 directly phosphorylates GSK3\\u03b2 not established\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended CaMKII\\u03b2 (and CaMKII broadly) into non-neuronal physiology: regulating autophagic flux via MLKL phosphorylation, adipocyte insulin signaling, and stress resilience via TARP\\u03b3-8/AMPAR.\",\n      \"evidence\": \"Genetic/pharmacological MLKL studies with autophagy flux assays; adipocyte-specific CAMK2 knockout with metabolic phenotyping; in vivo ventral hippocampus manipulation with phosphorylation and behavioral readouts\",\n      \"pmids\": [\"34282994\", \"34303021\", \"34113835\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Isoform-specific contribution of CaMKII\\u03b2 in autophagy and adipocyte roles not fully separated from other CaMKII isoforms\", \"MLKL and TARP\\u03b3-8 phosphosite mapping for CaMKII\\u03b2 not detailed here\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed distinct CaMKII\\u03b2 autophosphorylation states differentially control sleep induction versus maintenance, and that primate-specific splice isoforms with altered kinetics affect LTP, linking phospho-state and splicing to higher functions.\",\n      \"evidence\": \"Phosphomimetic/phosphoblock mutants with EEG sleep analysis; CRISPR knock-in of human branch point into mouse with LTP electrophysiology\",\n      \"pmids\": [\"36194579\", \"36543542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Circuit-level basis of sleep-state control not resolved\", \"Substrate-specificity changes of primate isoforms not fully mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked CaMKII\\u03b2 to spine calcium homeostasis, showing knockdown reduces store-operated calcium entry and causes mushroom spine loss.\",\n      \"evidence\": \"siRNA knockdown in hippocampal neurons with calcium imaging, spine morphology, and KN-62 inhibition\",\n      \"pmids\": [\"35079728\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting CaMKII\\u03b2 to nSOCE channels not defined\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined an indirect signaling route: CaMKII\\u03b2 activates ERK1/2, which phosphorylates GABAB1 to trigger lysosomal receptor degradation, showing CaMKII\\u03b2 acts upstream rather than directly on the receptor.\",\n      \"evidence\": \"Site-directed mutagenesis of GABAB1 phosphosites, ERK1/2 inhibition, and CaMKII\\u03b2 manipulation with degradation assays under physiological and ischemic conditions\",\n      \"pmids\": [\"37686242\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The direct CaMKII\\u03b2 substrate linking it to ERK1/2 activation not identified\", \"Physiological context of GABAB downregulation incompletely defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved the CaMKII\\u03b2 hub architecture, showing coexisting 14-mer and 16-mer assemblies that are less stable than CaMKII\\u03b1 hubs, providing a structural basis for isoform-specific oligomer behavior.\",\n      \"evidence\": \"X-ray crystallography (3.1 \\u00c5 14-mer, 3.4 \\u00c5 16-mer), mass photometry, temperature denaturation, and rational dimer mutagenesis\",\n      \"pmids\": [\"38501502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of variable oligomer size in cells not established\", \"Relationship of hub stability to actin targeting not addressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Implicated CaMKII\\u03b2 in neuromuscular junction stability, showing CaMKII\\u03b2 overexpression normalizes endplate fragmentation and corrects HDAC4-regulated synaptic gene programs in Myotonic Dystrophy type I models.\",\n      \"evidence\": \"HSALR and Mbnl1\\u0394E3/\\u0394E3 DM1 mouse models with AAV CaMKII\\u03b2 overexpression, endplate morphology, gene expression, and AChR turnover assays\",\n      \"pmids\": [\"38769542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct CaMKII\\u03b2 substrates at the NMJ not identified\", \"Whether kinase activity mediates the rescue not separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified spastin as a CaMKII\\u03b2 substrate (Ser233/Ser562) stabilized against degradation, mechanistically connecting CaMKII\\u03b2 to microtubule severing and neurite outgrowth.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay mapping phosphosites, ubiquitination and degradation assays, neurite outgrowth, mEPSC recording, and behavioral tests\",\n      \"pmids\": [\"40645772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo requirement for spastin phosphorylation by CaMKII\\u03b2 across tissues not established\", \"How phosphorylation reduces ubiquitination mechanistically not detailed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the distinct molecular axes of CaMKII\\u03b2 \\u2014 actin structural targeting, defined substrate phosphorylation (Cdc20, LIMK1, spastin, MLKL), and scaffold/receptor functions (Arc, drebrin) \\u2014 are coordinated through its splice variants, phospho-state, and hub oligomerization within a single cell remains unresolved, and the bulk of its in vivo substrate landscape is still being defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most CaMKII substrates identified by phosphoproteomics in double-KO tissue lack direct validation [#30]\", \"No unified model relating hub stability/oligomer size to functional output\", \"Isoform-specific versus shared functions across CaMKII\\u03b1/\\u03b2 incompletely separated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [3, 6, 16, 22, 25]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 1, 2, 7, 10, 29]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 3, 6, 25]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 8, 13]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [5, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 1, 2, 29]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 13, 17, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 9, 10, 5]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [14, 15, 22]}\n    ],\n    \"complexes\": [\"CaMKII holoenzyme (CaMKII\\u03b1/\\u03b2 heterooligomer)\"],\n    \"partners\": [\"CAMK2A\", \"Arc\", \"PCM1\", \"Cdc20\", \"DBN1\", \"LIMK1\", \"SPAST\", \"GSK3B\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}